vs

Side-by-side financial comparison of Consensus Cloud Solutions, Inc. (CCSI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Consensus Cloud Solutions, Inc. is the larger business by last-quarter revenue ($87.1M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 0.1%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $7.3M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.6%).

Consensus Cloud Solutions, Inc. is a provider of cloud-based secure information delivery and digital workflow solutions. Its core offerings include encrypted digital fax, secure document exchange, and process automation tools, serving clients across healthcare, legal, financial services and enterprise sectors, with a primary operating market in North America.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

CCSI vs PBYI — Head-to-Head

Bigger by revenue
CCSI
CCSI
1.2× larger
CCSI
$87.1M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+27.6% gap
PBYI
27.7%
0.1%
CCSI
More free cash flow
PBYI
PBYI
$7.1M more FCF
PBYI
$14.4M
$7.3M
CCSI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-0.6%
CCSI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCSI
CCSI
PBYI
PBYI
Revenue
$87.1M
$75.5M
Net Profit
$20.5M
Gross Margin
80.0%
69.3%
Operating Margin
41.1%
22.7%
Net Margin
23.5%
Revenue YoY
0.1%
27.7%
Net Profit YoY
13.5%
EPS (diluted)
$1.06
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCSI
CCSI
PBYI
PBYI
Q4 25
$87.1M
$75.5M
Q3 25
$87.8M
$54.5M
Q2 25
$87.7M
$52.4M
Q1 25
$87.1M
$46.0M
Q4 24
$87.0M
$59.1M
Q3 24
$87.8M
$80.5M
Q2 24
$87.5M
$47.1M
Q1 24
$88.1M
$43.8M
Net Profit
CCSI
CCSI
PBYI
PBYI
Q4 25
$20.5M
Q3 25
$22.1M
$8.8M
Q2 25
$20.8M
$5.9M
Q1 25
$21.2M
$3.0M
Q4 24
$18.1M
Q3 24
$21.1M
$20.3M
Q2 24
$23.9M
$-4.5M
Q1 24
$26.4M
$-4.8M
Gross Margin
CCSI
CCSI
PBYI
PBYI
Q4 25
80.0%
69.3%
Q3 25
80.0%
77.7%
Q2 25
79.9%
76.5%
Q1 25
79.3%
77.1%
Q4 24
79.5%
76.4%
Q3 24
79.9%
63.9%
Q2 24
80.4%
77.4%
Q1 24
80.7%
75.5%
Operating Margin
CCSI
CCSI
PBYI
PBYI
Q4 25
41.1%
22.7%
Q3 25
43.2%
17.6%
Q2 25
44.5%
12.7%
Q1 25
43.0%
8.7%
Q4 24
38.4%
22.6%
Q3 24
43.8%
27.4%
Q2 24
45.6%
-4.6%
Q1 24
42.7%
-5.3%
Net Margin
CCSI
CCSI
PBYI
PBYI
Q4 25
23.5%
Q3 25
25.2%
16.2%
Q2 25
23.7%
11.2%
Q1 25
24.3%
6.5%
Q4 24
20.8%
Q3 24
24.1%
25.2%
Q2 24
27.3%
-9.6%
Q1 24
29.9%
-11.0%
EPS (diluted)
CCSI
CCSI
PBYI
PBYI
Q4 25
$1.06
$0.26
Q3 25
$1.15
$0.17
Q2 25
$1.07
$0.12
Q1 25
$1.07
$0.06
Q4 24
$0.92
$0.40
Q3 24
$1.09
$0.41
Q2 24
$1.24
$-0.09
Q1 24
$1.37
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCSI
CCSI
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$74.7M
$97.5M
Total DebtLower is stronger
$558.4M
$22.7M
Stockholders' EquityBook value
$13.8M
$130.3M
Total Assets
$663.8M
$216.3M
Debt / EquityLower = less leverage
40.54×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCSI
CCSI
PBYI
PBYI
Q4 25
$74.7M
$97.5M
Q3 25
$97.6M
$94.4M
Q2 25
$57.9M
$96.0M
Q1 25
$53.4M
$93.2M
Q4 24
$33.5M
$101.0M
Q3 24
$54.6M
$96.7M
Q2 24
$49.2M
$96.8M
Q1 24
$61.5M
$107.2M
Total Debt
CCSI
CCSI
PBYI
PBYI
Q4 25
$558.4M
$22.7M
Q3 25
$578.6M
$34.0M
Q2 25
$578.2M
$45.3M
Q1 25
$583.7M
$56.7M
Q4 24
$593.0M
$68.0M
Q3 24
$612.5M
$79.3M
Q2 24
$642.8M
$90.7M
Q1 24
$671.7M
$102.0M
Stockholders' Equity
CCSI
CCSI
PBYI
PBYI
Q4 25
$13.8M
$130.3M
Q3 25
$-2.6M
$115.3M
Q2 25
$-26.5M
$104.7M
Q1 25
$-49.4M
$97.1M
Q4 24
$-79.5M
$92.1M
Q3 24
$-93.2M
$71.1M
Q2 24
$-124.4M
$48.5M
Q1 24
$-151.8M
$51.0M
Total Assets
CCSI
CCSI
PBYI
PBYI
Q4 25
$663.8M
$216.3M
Q3 25
$675.0M
$202.9M
Q2 25
$641.5M
$194.9M
Q1 25
$629.6M
$196.2M
Q4 24
$602.2M
$213.3M
Q3 24
$622.5M
$220.7M
Q2 24
$608.5M
$205.0M
Q1 24
$620.8M
$214.1M
Debt / Equity
CCSI
CCSI
PBYI
PBYI
Q4 25
40.54×
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCSI
CCSI
PBYI
PBYI
Operating Cash FlowLast quarter
$15.2M
$14.4M
Free Cash FlowOCF − Capex
$7.3M
$14.4M
FCF MarginFCF / Revenue
8.4%
19.1%
Capex IntensityCapex / Revenue
9.1%
0.0%
Cash ConversionOCF / Net Profit
0.74×
TTM Free Cash FlowTrailing 4 quarters
$105.9M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCSI
CCSI
PBYI
PBYI
Q4 25
$15.2M
$14.4M
Q3 25
$51.6M
$9.7M
Q2 25
$28.3M
$14.1M
Q1 25
$40.9M
$3.6M
Q4 24
$11.1M
$15.6M
Q3 24
$41.6M
$11.0M
Q2 24
$24.4M
$1.0M
Q1 24
$44.7M
$11.2M
Free Cash Flow
CCSI
CCSI
PBYI
PBYI
Q4 25
$7.3M
$14.4M
Q3 25
$44.4M
$9.7M
Q2 25
$20.3M
$14.1M
Q1 25
$33.7M
$3.6M
Q4 24
$3.1M
$15.6M
Q3 24
$33.6M
$11.0M
Q2 24
$15.8M
$1.0M
Q1 24
$35.8M
FCF Margin
CCSI
CCSI
PBYI
PBYI
Q4 25
8.4%
19.1%
Q3 25
50.6%
17.7%
Q2 25
23.2%
26.8%
Q1 25
38.7%
7.7%
Q4 24
3.6%
26.4%
Q3 24
38.3%
13.7%
Q2 24
18.1%
2.1%
Q1 24
40.6%
Capex Intensity
CCSI
CCSI
PBYI
PBYI
Q4 25
9.1%
0.0%
Q3 25
8.2%
0.0%
Q2 25
9.1%
0.0%
Q1 25
8.3%
0.1%
Q4 24
9.2%
0.0%
Q3 24
9.1%
0.0%
Q2 24
9.8%
0.0%
Q1 24
10.1%
0.0%
Cash Conversion
CCSI
CCSI
PBYI
PBYI
Q4 25
0.74×
Q3 25
2.34×
1.10×
Q2 25
1.36×
2.41×
Q1 25
1.94×
1.21×
Q4 24
0.62×
Q3 24
1.97×
0.54×
Q2 24
1.02×
Q1 24
1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons